Log in

Relevant bibliographies by topics / Differentiated thyroid cancers

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Differentiated thyroid cancers'

Author: Grafiati

Published: 7 December 2024

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Differentiated thyroid cancers.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Differentiated thyroid cancers"

1

Krause, Kerstin, Stefan Karger, Oliver Gimm, et al. "Characterisation of DEHAL1 expression in thyroid pathologies." European Journal of Endocrinology 156, no. 3 (2007): 295–301. http://dx.doi.org/10.1530/eje-06-0596.

Full text

Abstract:

Iodotyrosine dehalogenase 1 (DEHAL1) is a transmembrane protein involved in the recycling of iodide in the human thyroid. The aim of the present study was (I) to investigate whether DEHAL1 expression is different in differentially functioning thyroid pathologies and (II) to evaluate DEHAL1 as a possible marker of thyroid cell differentiation. Design and methods: Real-time PCR for DEHAL1 and its isoform DEHAL1B was performed in a series of 105 thyroid specimens, including toxic thyroid nodules (TTN), Graves’ disease (GD) thyroids, benign cold thyroid nodules (CTN), normal thyroid tissues and th

APA, Harvard, Vancouver, ISO, and other styles

2

Nix, P., A. Nicolaides, and A. P. Coatesworth. "Thyroid cancer review 2: management of differentiated thyroid cancers." International Journal of Clinical Practice 59, no. 12 (2005): 1459–63. http://dx.doi.org/10.1111/j.1368-5031.2005.00672.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Colevas, A. Dimitrios, and Manisha H. Shah. "Evaluation of Patients with Disseminated or Locoregionally Advanced Thyroid Cancer: A Primer for Medical Oncologists." American Society of Clinical Oncology Educational Book, no. 32 (June 2012): 384–88. http://dx.doi.org/10.14694/edbook_am.2012.32.30.

Full text

Abstract:

Overview: Historically, patients with thyroid cancers are managed by endocrinologists, surgeons and radiation oncologists. Due to recent progress in this field with advances in treatment of thyroid cancer, medical oncologists are now commonly involved in care of patients with advanced thyroid cancers. In this manuscript, we describe general principles in management of patients with various types of thyroid cancers including differentiated, medullary and anaplastic thyroid cancers.

APA, Harvard, Vancouver, ISO, and other styles

4

Vaidya, Abhishek, and Madan Kapre. "Chapter 4: Surgery for Locally Advanced Thyroid Cancers." Journal of Head & Neck Physicians and Surgeons 12, Suppl 1 (2024): S16—S21. http://dx.doi.org/10.4103/jhnps.jhnps_6_24.

Full text

Abstract:

ABSTRACT A small proportion of Differentiated Thyroid Cancers (DTCs) may present with gross tumor extension outside the thyroid, these constitute the locally advanced thyroid cancers. They often carry worse prognosis in terms of local recurrence and disease free survival. The surgical management of these locally advanced thyroid cancers may be challenging. This narrative review provides an overview of the management strategy of such thyroid cancers.

APA, Harvard, Vancouver, ISO, and other styles

5

Hartl, Dana M., Joanne Guerlain, Ingrid Breuskin, et al. "Thyroid Lobectomy for Low to Intermediate Risk Differentiated Thyroid Cancer." Cancers 12, no. 11 (2020): 3282. http://dx.doi.org/10.3390/cancers12113282.

Full text

Abstract:

Many recent publications and guidelines have promoted a “more is less” approach in terms of treatment for low to intermediate risk differentiated thyroid cancer (DTC), which comprise the vast majority of thyroid cancers: less extensive surgery, less radioactive iodine, less or no thyroid hormone suppression, and less frequent or stringent follow-up. Following this approach, thyroid lobectomy has been proposed as a means of decreasing short- and long-term postoperative morbidity while maintaining an excellent prognosis for tumors meeting specific macroscopic and microscopic criteria. This artic

APA, Harvard, Vancouver, ISO, and other styles

6

Min, Seonyoung, and Hyunseok Kang. "What's New in Molecular Targeted Therapies for Thyroid Cancer?" Korean Society for Head and Neck Oncology 37, no. 2 (2021): 1–9. http://dx.doi.org/10.21593/kjhno/2021.37.2.1.

Full text

Abstract:

Thyroid cancer refers to various cancers arising from thyroid gland. Differentiated thyroid cancers (DTCs) include papillary, follicular, and Hurthle cell carcinomas and represent cancers retain normal thyroid functions such as iodine uptake. Radioactive iodine (RAI) is generally used for upfront treatment of metastatic DTCs, but RAI refractory DTCs remain to be clinical challenges. Sorafenib and lenvatinib were approved for the treatment of RAI refractory DTCs and more recently, genomics-based targeted therapies have been developed for NTRK and RET gene fusion-positive DTCs. Poorly differenti

APA, Harvard, Vancouver, ISO, and other styles

7

Iftikhar, Haissan, Mubasher Ikram, Adnan Muhammad, and Karim Nathani. "Unusual Presentation of Differentiated Thyroid Cancer Metastasis." International Archives of Otorhinolaryngology 22, no. 02 (2017): 167–70. http://dx.doi.org/10.1055/s-0037-1604038.

Full text

Abstract:

Introduction The rates of thyroid cancers are on a rise, especially well-differentiated thyroid cancers. This could be partly due to newer diagnostic modalities, like high-resolution ultrasound, that can pick up smaller lesions. Differentiated thyroid cancers with distant metastases are not common, and even rarer is the initial presentation with complaints not related to the neck. Objectives The objective of this series was to study and report the unusual cases of patients with differentiated thyroid cancer with distant metastasis. There is a lack of data in the literature on these cases, and

APA, Harvard, Vancouver, ISO, and other styles

8

Suteau, Valentine, Mathilde Munier, Claire Briet, and Patrice Rodien. "Sex Bias in Differentiated Thyroid Cancer." International Journal of Molecular Sciences 22, no. 23 (2021): 12992. http://dx.doi.org/10.3390/ijms222312992.

Full text

Abstract:

Differentiated thyroid cancers are more frequent in women than in men. These different frequencies may depend on differences in patient’s behavior and in thyroid investigations. However, an impact on sexual hormones is likely, although this has been insufficiently elucidated. Estrogens may increase the production of mutagenic molecules in the thyroid cell and favor the proliferation and invasion of tumoral cells by regulating both the thyrocyte enzymatic machinery and the inflammatory process associated with tumor growth. On the other hand, the worse prognosis of thyroid cancer associated with

APA, Harvard, Vancouver, ISO, and other styles

9

Satapathy, Swayamjeet, and Chandrasekhar Bal. "Chapter 11: Pediatric Differentiated Thyroid Cancers." Journal of Head & Neck Physicians and Surgeons 12, Suppl 1 (2024): S58—S64. http://dx.doi.org/10.4103/jhnps.jhnps_13_24.

Full text

Abstract:

ABSTRACT The document discusses pediatric differentiated thyroid cancer (DTC), focusing on papillary thyroid carcinoma (PTC), which is increasingly prevalent globally, including in India. Despite a more aggressive initial presentation in children, the long-term prognosis is generally positive. Key differences between pediatric and adult DTC are highlighted, such as a higher risk of malignancy in children with thyroid nodules and common RET/PTC gene rearrangements. There is a debate on the age cutoff for defining pediatric DTC, but the document suggests that 18 years is considered appropriate i

APA, Harvard, Vancouver, ISO, and other styles

10

Salehian, Behrouz, Zhong Liu, and Fouad Kandeel. "Genetic Alterations in Differentiated Thyroid Cancers." Endocrine, Metabolic & Immune Disorders - Drug Targets 9, no. 3 (2009): 257–68. http://dx.doi.org/10.2174/187153009789044338.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Differentiated thyroid cancers"

1

Sheremet, M. I. "Differential diagnosis of nodular goiter on the background autoimmune thyroiditis and differentiated thyroid cancers." Thesis, БДМУ, 2022. http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/19664.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Leboulleux, Sophie. "Place de l'iode 131 et de l'imagerie scintigraphique dans la prise en charge des cancers différenciés de la thyroïde." Thesis, Paris 11, 2013. http://www.theses.fr/2013PA11T062.

Full text

Abstract:

Le traitement initial des cancers différenciés de la thyroïde (CTD) consiste en une thyroïdectomie totale suivie, dans de nombreux cas par l’administration d’iode 131. Après thyroïdectomie totale, un traitement par iode 131 est indiqué en fonction des caractéristiques tumorales initiales. Chez les patients à risque élevé de rechute il est recommandé d’administrer une forte activité d’iode 131. Chez les patients à très faible risque il est recommandé de ne pas administrer d’iode 131. Dans le groupe intermédiaire, il a été montré par deux études prospectives multicentriques randomisées (ESTIMABL

APA, Harvard, Vancouver, ISO, and other styles

3

D'Andréa, Grégoire. "Apport de l'intelligence artificielle, de la protéomique et de la métabolomique dans la prise en charge des cancers thyroïdiens différenciés." Electronic Thesis or Diss., Université Côte d'Azur, 2024. http://www.theses.fr/2024COAZ6011.

Full text

Abstract:

Les nodules thyroïdiens (NT) sont fréquents, et seuls 5-10% s'avèrent être cancéreux. La stratégie diagnostique qu'ils imposent est bien codifiée et permet de stratifier leur risque de malignité, mais ne permet toutefois pas de conclure sur la nature des NT dans 20-25% des cas, on parle alors de NT indéterminés (NTI). Cette situation conduit souvent à la réalisation d'une chirurgie diagnostique, retrouvant 66% de NT bénins. L'amélioration du diagnostic de ces NTI reste donc cruciale. Les cancers thyroïdiens différenciés (CDT) sont de très bon pronostic, grâce à des traitements reposant sur la

APA, Harvard, Vancouver, ISO, and other styles

4

Lang, Brian. "Cancer staging for differentiated thyroid carcinoma." Click to view the E-thesis via HKUTO, 2006. http://sunzi.lib.hku.hk/hkuto/record/B36916134.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Mehrotra, Pallavi. "Molecular characteristics of differentiated thyroid cancer." Thesis, University of Newcastle upon Tyne, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.405074.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Chow, Sin-ming, and 周倩明. "Differentiated thyroid cancer in Hong Kong." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2007. http://hub.hku.hk/bib/B41290847.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Lang, Brian, and 梁熊顯. "Cancer staging for differentiated thyroid carcinoma." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2006. http://hub.hku.hk/bib/B36916134.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Chow, Sin-ming. "Differentiated thyroid cancer in Hong Kong." Click to view the E-thesis via HKUTO, 2007. http://sunzi.lib.hku.hk/hkuto/record/B41290847.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Ciappuccini, Renaud. "Apport de l'imagerie fonctionnelle par TEMP/TDM et TEP/TDM dans la prise en charge des cancers différenciés de la thyroïde Incremental Value of a Dedicated Head and Neck Acquisition during 18F-FDG PET/CT in Patients with Differentiated Thyroid Cancer Full text links full-text provider logo Actions Favorites Share Page navigation Title & authors Abstract Conflict of interest statement Figures Similar articles Cited by References Related information LinkOut - more resources EJNMMI Res . 2018 Dec 3;8(1):104. doi: 10.1186/s13550-018-0461-x. Optimization of a dedicated protocol using a small-voxel PSF reconstruction for head-and-neck 18 FDG PET/CT imaging in differentiated thyroid cancer 78 Lymph node involvement in head-and-neck and thyroid cancers with digital PET/CT: the impact of ultra-high definition voxels and point-spread function Tumor burden of persistent disease in patients with differentiated thyroid cancer: correlation with postoperative risk-stratification and impact on outcome 133 18F-Fluorocholine PET/CT is a highly sensitive but poorly specific tool for identifying malignancy in thyroid nodules with indeterminate cytology: The Chocolate study PSMA expression in neovasculature of persistent/recurrent differentiated thyroid cancerin the neck: relationship with radioiodine uptake, 18Fluorodeoxyglucose avidity and outcome." Thesis, Normandie, 2020. http://www.theses.fr/2020NORMC424.

Full text

Abstract:

L’imagerie scintigraphique des cancers thyroïdiens différenciés (CTD) présente la particularité d’utiliser deux radiopharmaceutiques, l’iode 131 (131I) et le 18-Fluorodésoxyglucose (18FDG). La fixation de ces traceurs dépend habituellement du degré de différenciation et de l’agressivité de la tumeur. L’objectif de ce travail était d’étudier l’apport de différents aspects techniques et d’instrumentation, à savoir l’imagerie hybride par TEMP/TDM et TEP/TDM, la point-spread function (PSF), la taille des voxels et la technologie TEP digitale, et d’explorer si d’autres traceurs TEP pouvaient présen

APA, Harvard, Vancouver, ISO, and other styles

10

Marcelino, Ana Sousa. "Targeting thyroid stimulating hormone receptors in radioiodine resistent de-differentiated thyroid cancer." Thesis, Queen Mary, University of London, 2012. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.576914.

Full text

Abstract:

The most common type of thyroid cancer, differentiated thyroid cancer (DTC), is diagnosed by radioactive iodine whole body scanning (WBS) and treated with radiotherapy using iodine-13I C31 I). The success of this diagnosis/treatment approach relies on the relatively selective localisation of the sodium/iodide symporter (NIS) in cells of the thyroid gland. However, in some de-differentiated thyroid cancers, NIS expression is lost. This results in the inability of WBS to stage the disease and it also decreases the effectiveness of treatment with 131 I. A number of reports have shown that de-diff

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Differentiated thyroid cancers"

1

Greene, Frederick L., and Andrzej L. Komorowski, eds. Clinical Approach to Well-differentiated Thyroid Cancers. Springer India, 2012. http://dx.doi.org/10.1007/978-81-322-2568-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Mancino, Anne T., and Lawrence T. Kim, eds. Management of Differentiated Thyroid Cancer. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-54493-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Roman, Sanziana A., Julie Ann Sosa, and Carmen C. Solórzano, eds. Management of Thyroid Nodules and Differentiated Thyroid Cancer. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-43618-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Roman, Sanziana A., Wen T. Shen, and Julie Ann Sosa, eds. Controversies in Thyroid Nodules and Differentiated Thyroid Cancer. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-37135-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Greene, Frederick L., and Andrzej L. Komorowski. Clinical Approach to Well-differentiated Thyroid Cancers. Springer, 2016.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Greene, Frederick L., and Andrzej L. Komorowski. Clinical Approach to Well-Differentiated Thyroid Cancers. Springer, 2015.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Greene, Frederick L., and Andrzej L. Komorowski. Clinical Approach to Well-differentiated Thyroid Cancers. Springer, 2015.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Mancino, Anne T., and Lawrence T. Kim. Management of Differentiated Thyroid Cancer. Springer International Publishing AG, 2017.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Mancino, Anne T., and Lawrence T. Kim. Management of Differentiated Thyroid Cancer. Springer International Publishing AG, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Roman, Sanziana A., Julie Ann Sosa, and Carmen C. Solórzano. Management of Thyroid Nodules and Differentiated Thyroid Cancer: A Practical Guide. Springer, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Differentiated thyroid cancers"

1

D'cruz, Anil, and Richa Vaish. "Surgical Management of Differentiated Thyroid Cancers." In Thyroid Surgery. CRC Press, 2020. http://dx.doi.org/10.1201/9780429086076-14.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Ryś, Janusz, and Joanna Wysocka. "Pathology of Differentiated Thyroid Cancers." In Clinical Approach to Well-differentiated Thyroid Cancers. Springer India, 2012. http://dx.doi.org/10.1007/978-81-322-2568-3_2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Wysocki, Wojciech M., Andrzej L. Komorowski, and Frederick L. Greene. "Staging of Differentiated Thyroid Cancer." In Clinical Approach to Well-differentiated Thyroid Cancers. Springer India, 2012. http://dx.doi.org/10.1007/978-81-322-2568-3_5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Gwyther, Stephen J. "Imaging in Thyroid Cancer." In Clinical Approach to Well-differentiated Thyroid Cancers. Springer India, 2012. http://dx.doi.org/10.1007/978-81-322-2568-3_4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Burnison, C. Michele. "External Beam Radiation Therapy in the Treatment of Differentiated Thyroid Cancers." In Thyroid Cancer. Springer US, 2011. http://dx.doi.org/10.1007/978-1-4614-0875-8_14.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Barczyński, Marcin. "Surgical Treatment of Thyroid Cancer." In Clinical Approach to Well-differentiated Thyroid Cancers. Springer India, 2012. http://dx.doi.org/10.1007/978-81-322-2568-3_7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Iacconi, Pietro, and Carmine De Bartolomeis. "Postoperative Complications in Thyroid Surgery." In Clinical Approach to Well-differentiated Thyroid Cancers. Springer India, 2012. http://dx.doi.org/10.1007/978-81-322-2568-3_12.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Yip, Linwah, and Sally E. Carty. "Differentiated Thyroid Cancers of Follicular Cell Origin." In Endocrine Neoplasia. Springer US, 2009. http://dx.doi.org/10.1007/978-1-4419-0857-5_3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Komorowski, Artur, and Andrzej L. Komorowski. "Clinical Evaluation of the Thyroid Gland." In Clinical Approach to Well-differentiated Thyroid Cancers. Springer India, 2012. http://dx.doi.org/10.1007/978-81-322-2568-3_3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Gal, Istvan. "Minimally Invasive Approach to the Thyroid." In Clinical Approach to Well-differentiated Thyroid Cancers. Springer India, 2012. http://dx.doi.org/10.1007/978-81-322-2568-3_8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Differentiated thyroid cancers"

1

Mamman, Hussaini, Shuib Basri, Sadiq Musa Liman, et al. "Low-Code Machine Learning for Predicting Differentiated Thyroid Cancer Reoccurrence." In 2024 16th International Conference on Knowledge and System Engineering (KSE). IEEE, 2024. https://doi.org/10.1109/kse63888.2024.11063497.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Dogra, Akash, Srishti Sharma, Daksh Rawat, Harshit Narang, Satvik Vats, and Vikrant Sharma. "Using XGBoost for Risk Stratification in Differentiated Thyroid Cancer Recurrence Prediction." In 2024 IEEE 3rd World Conference on Applied Intelligence and Computing (AIC). IEEE, 2024. http://dx.doi.org/10.1109/aic61668.2024.10731128.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Ahmad, Mohammad Al-Sayed, and Jude Haddad. "An Explainable AI Model for Predicting the Recurrence of Differentiated Thyroid Cancer." In 2024 Second Jordanian International Biomedical Engineering Conference (JIBEC). IEEE, 2024. https://doi.org/10.1109/jibec63210.2024.10932125.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Zhu, Junhao, Pengbo Gao, Feng Hu, and Hong Yu. "Deep Learning-Based Recurrence Risk Prediction for Differentiated Thyroid Cancer Using Local Clustering Contrastive Learning." In 2024 IEEE International Conference on Medical Artificial Intelligence (MedAI). IEEE, 2024. https://doi.org/10.1109/medai62885.2024.00082.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Imtiaz, Irsa, Attique Ur Rehman, Sabeen Javaid, et al. "The Future of Differentiated Thyroid Cancer Recurrence Prediction Using a Machine Learning Framework Advancements, Challenges, and Prospects." In 2024 International Conference on Emerging Trends in Networks and Computer Communications (ETNCC). IEEE, 2024. https://doi.org/10.1109/etncc63262.2024.10767492.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

AMIT, MORAN, shorook Na’ara, Tomer Charas, and Ziv gil. "Abstract 2879: PIGU modulates radioactive iodine uptake in differentiated thyroid cancers." In Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-2879.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Stephen, Josena K., Kang Mei Chen, Jason Merritt, et al. "Abstract 3361: Methylome differences in differentiated thyroid cancers and benign adenomas." In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-3361.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Copland, John, Kendall Schick, Justyna Gleba, et al. "324 Sensitizing poorly differentiated thyroid cancers to TSHR-CART cell therapy with MEK inhibitors." In SITC 37th Annual Meeting (SITC 2022) Abstracts. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/jitc-2022-sitc2022.0324.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Begić, Amela, and Elma Kučukalić-Selimović. "RADIOIODINE THERAPY OF DIFFERENTIATED THYROID CANCER – PRINCIPLES AND PRACTICE." In Tumori štitnjače u kliničkoj praksi. Akademija nauka i umjetnosti Bosne i Hercegovine, 2016. http://dx.doi.org/10.5644/pi2016.167.04.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

K, Bharath, and A. Sai Sabitha. "Predicting Recurrence in Differentiated Thyroid Cancer: A Machine Learning Approach." In 2024 International Conference on Advances in Data Engineering and Intelligent Computing Systems (ADICS). IEEE, 2024. http://dx.doi.org/10.1109/adics58448.2024.10533649.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Differentiated thyroid cancers"

1

Alessa, Mohammed, Tayba Wahedi, Jumanah Alsairafi, et al. Prevalence of Thyroid cancer in Saudi Arabis: Systematic review and Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.9.0088.

Full text

Abstract:

Review question / Objective: What is the prevalence of Thyroid cancer among population in kingdom of Saudi Arabia?. The aim of this systematic review is to scrutinize the prevalence of thyroid cancer (TC) in Saudi Arabia and assess the relative frequency of subgroups related to types of thyroid cancer, age, and gender. Condition being studied: Thyroid cancer is an abnormal growth of cells that starts in the thyroid gland. There is four types of differentiated thyroid cancer, three of these cancer develop from the follicular cells, the papillary thyroid cancer, follicular thyroid cancer, Hürthl

APA, Harvard, Vancouver, ISO, and other styles

2

Zhao, Hao, Chunhao Liu, Yanlong Li, and Xiaoyi Li. Prognostic factors for survival in differentiated thyroid cancer with pulmonary metastases: a protocol of systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.2.0026.

Full text

Abstract:

Pulmonary metastasis (PM) is the most common form of distance metastasis in differentiated thyroid cancer (DTC), which has a poor prognosis. However, the prognostic risk factors are not yet well identified and analyzed. This systematic review and meta-analysis aims to fill this blank though identifying and discussing survival prognostic risk factors systematically for DTC patients with PM. Pulmonary metastasis (PM) is the most common form of distance metastasis in differentiated thyroid cancer (DTC), which has a poor prognosis. However, the prognostic risk factors are not yet well identified a

APA, Harvard, Vancouver, ISO, and other styles

3

Wang, Yizhen, Zhicheng Jin, Fang Zhang, and Yangting Mao. The efficacy and influencing factors of radioactive iodine in the treatment of patients with lung metastasis of differentiated thyroid cancer: a meta analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.11.0093.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!